Open AccessMaintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma
Author(s) -
Yurika Noguchi,
Noriyoshi Iriyama,
Hiromichi Takahashi,
Y. Uchino,
Masaru Nakagawa,
Takashi Hamada,
Kazuhide Iizuka,
Takashi Koike,
Kazuya Kurihara,
Toshihide Endo,
Tsutomu Yoshida,
Katsuhiro Miura,
Tomohiro Nakayama,
Yoshihiro Hatta,
Masami Takei
Publication year - 2021
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10006
Subject(s) - bortezomib , maintenance therapy , medicine , multiple myeloma , dexamethasone , regimen , induction therapy , surgery , oncology , chemotherapy
Here, we investigated whether bortezomib as a maintenance therapy affected outcomes in transplant-ineligible patients with multiple myeloma (MM).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom